Fig. 2

(A) Kaplan–Meier recurrence-free survival curves for metastasis-naive RCC patients by pathologic subtypes. (B) Kaplan–Meier overall survival curves for metastasis-naive RCC patients by pathologic subtypes. (C) Kaplan–Meier overall survival curves for the entire cohort including metastasis-naive and metastatic patients by pathologic subtypes.